小泛素样修饰（SUMO）化与去小泛素样修饰（SUMO）化：与生命过程的较量
SUMOylation and De-SUMOylation: wrestling with life's processes.
作者信息
Yeh Edward T H
机构信息
Department of Cardiology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
出版信息
J Biol Chem. 2009 Mar 27;284(13):8223-7. doi: 10.1074/jbc.R800050200. Epub 2008 Nov 13.
Abstract
The small ubiquitin-like modifier (SUMO) is a ubiquitin-like protein that covalently modifies a large number of cellular proteins. SUMO modification has emerged as an important regulatory mechanism for protein function and localization. SUMOylation is a dynamic process that is mediated by activating (E1), conjugating (E2), and ligating (E3) enzymes and readily reversed by a family of ubiquitin-like protein-specific proteases (Ulp) in yeast and sentrin/SUMO-specific proteases (SENP) in human. This review will focus on the de-SUMOylating enzymes with special attention to their biological function.
摘要
小泛素样修饰蛋白（SUMO）是一种类泛素蛋白，可共价修饰大量细胞蛋白。SUMO修饰已成为蛋白质功能和定位的重要调控机制。SUMO化是一个动态过程，由激活酶（E1）、缀合酶（E2）和连接酶（E3）介导，并可被酵母中的泛素样蛋白特异性蛋白酶家族（Ulp）和人类中的sentrin/SUMO特异性蛋白酶（SENP）轻易逆转。本综述将聚焦于去SUMO化酶，特别关注它们的生物学功能。
相似文献
1
SUMOylation and De-SUMOylation: wrestling with life's processes.
J Biol Chem. 2009 Mar 27;284(13):8223-7. doi: 10.1074/jbc.R800050200. Epub 2008 Nov 13.
2
SUMO-specific proteases and isopeptidases of the SENP family at a glance.
J Cell Sci. 2018 Mar 20;131(6):jcs211904. doi: 10.1242/jcs.211904.
3
The function of SUMOylation and its crucial roles in the development of neurological diseases.
FASEB J. 2021 Apr;35(4):e21510. doi: 10.1096/fj.202002702R.
4
E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.
J Biol Chem. 2014 May 30;289(22):15810-9. doi: 10.1074/jbc.M114.572081. Epub 2014 Apr 21.
5
Small ubiquitin-related modifier (SUMO)-1 promotes glycolysis in hypoxia.
J Biol Chem. 2011 Feb 11;286(6):4718-26. doi: 10.1074/jbc.M110.115931. Epub 2010 Dec 1.
6
Disruption of SUMO-specific protease 2 induces mitochondria mediated neurodegeneration.
PLoS Genet. 2014 Oct 9;10(10):e1004579. doi: 10.1371/journal.pgen.1004579. eCollection 2014 Oct.
7
SUMO: From Bench to Bedside.
Physiol Rev. 2020 Oct 1;100(4):1599-1619. doi: 10.1152/physrev.00025.2019.
8
CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking.
J Biol Chem. 2013 Aug 23;288(34):24316-31. doi: 10.1074/jbc.M113.474924. Epub 2013 Jul 8.
9
Wrestling with stress: roles of protein SUMOylation and deSUMOylation in cell stress response.
IUBMB Life. 2014 Feb;66(2):71-7. doi: 10.1002/iub.1244. Epub 2014 Jan 27.
10
Small ubiquitin-like modifier protein-specific protease 1 and prostate cancer.
Asian J Androl. 2009 Jan;11(1):36-8. doi: 10.1038/aja.2008.45. Epub 2008 Dec 22.
引用本文的文献
1
Structural basis for the human SENP5's SUMO isoform discrimination.
Nat Commun. 2025 May 22;16(1):4764. doi: 10.1038/s41467-025-60029-4.
2
Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives.
Signal Transduct Target Ther. 2025 May 19;10(1):170. doi: 10.1038/s41392-025-02249-0.
3
Downregulation of SENP1 impairs nuclear condensation of MEF2C and deteriorates ischemic cardiomyopathy.
Clin Transl Med. 2025 May;15(5):e70318. doi: 10.1002/ctm2.70318.
4
Immune regulation by the SUMO family.
Nat Rev Immunol. 2025 Mar 19. doi: 10.1038/s41577-025-01155-4.
5
SENP3-FIS1 axis promotes mitophagy and cell survival under hypoxia.
Cell Death Dis. 2024 Dec 5;15(12):881. doi: 10.1038/s41419-024-07271-8.
6
MicroRNA-145-5p inhibits the tumorigenesis of breast cancer through SENP2-regulated ubiquitination of ERK2.
Cell Mol Life Sci. 2024 Nov 23;81(1):461. doi: 10.1007/s00018-024-05505-8.
7
SUMO Regulation of Ion Channels in Health and Disease.
Physiology (Bethesda). 2025 Mar 1;40(2):0. doi: 10.1152/physiol.00034.2024. Epub 2024 Nov 5.
8
Exploring potential targets for natural product therapy of DN: the role of SUMOylation.
Front Pharmacol. 2024 Oct 4;15:1432724. doi: 10.3389/fphar.2024.1432724. eCollection 2024.
9
Crosstalk between SUMOylation and other post-translational modifications in breast cancer.
Cell Mol Biol Lett. 2024 Aug 10;29(1):107. doi: 10.1186/s11658-024-00624-3.
10
Suppression of SENP3 enhances macrophage alternative activation by mediating IRF4 de-SUMOylation in ESCC progression.
Cell Commun Signal. 2024 Aug 9;22(1):395. doi: 10.1186/s12964-024-01770-z.
本文引用的文献
1
SUMOylation of Krüppel-like transcription factor 5 acts as a molecular switch in transcriptional programs of lipid metabolism involving PPAR-delta.
Nat Med. 2008 Jun;14(6):656-66. doi: 10.1038/nm1756. Epub 2008 May 25.
2
The IL-6 family of cytokines modulates STAT3 activation by desumoylation of PML through SENP1 induction.
Biochem Biophys Res Commun. 2008 Jul 11;371(4):823-8. doi: 10.1016/j.bbrc.2008.04.179. Epub 2008 May 12.
3
The nucleolar SUMO-specific protease SENP3 reverses SUMO modification of nucleophosmin and is required for rRNA processing.
EMBO Rep. 2008 Mar;9(3):273-9. doi: 10.1038/embor.2008.3. Epub 2008 Feb 8.
4
SENP1 mediates TNF-induced desumoylation and cytoplasmic translocation of HIPK1 to enhance ASK1-dependent apoptosis.
Cell Death Differ. 2008 Apr;15(4):739-50. doi: 10.1038/sj.cdd.4402303. Epub 2008 Jan 25.
5
SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia.
Cell. 2007 Nov 2;131(3):584-95. doi: 10.1016/j.cell.2007.08.045.
6
SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress.
Nat Cell Biol. 2007 Nov;9(11):1253-62. doi: 10.1038/ncb1645. Epub 2007 Oct 14.
7
Induction of the SUMO-specific protease 1 transcription by the androgen receptor in prostate cancer cells.
J Biol Chem. 2007 Dec 28;282(52):37341-9. doi: 10.1074/jbc.M706978200. Epub 2007 Oct 11.
8
A nuclear envelope protein linking nuclear pore basket assembly, SUMO protease regulation, and mRNA surveillance.
J Cell Biol. 2007 Aug 27;178(5):813-27. doi: 10.1083/jcb.200702154.
9
Molecular basis of the redox regulation of SUMO proteases: a protective mechanism of intermolecular disulfide linkage against irreversible sulfhydryl oxidation.
FASEB J. 2008 Jan;22(1):127-37. doi: 10.1096/fj.06-7871com. Epub 2007 Aug 17.
10
The Ulp2 SUMO protease is required for cell division following termination of the DNA damage checkpoint.
Mol Cell Biol. 2007 Oct;27(19):6948-61. doi: 10.1128/MCB.00774-07. Epub 2007 Jul 30.
Zotero 插件